Journal of Life Science (생명과학회지)

Korean Society of Life Science (한국생명과학회)
권호 표지
DOI QR코드

DOI QR Code

Identification of Phosphoproteins Induced by AT1 Receptor Blocker Losartan

항고혈압 치료제 로사탄에 의해 인산화 되는 단백질 발굴

  • Published : 2008.07.30
Download PDF
⟨ Previous Next ⟩

Abstract

The angiotensin II receptor ($AT_1R$) antagonists are effective in treating patients with hypertension and showed beneficial effects in diabetes and other metabolic diseases. The beneficial effects of $AT_1R$ antagonists are mainly considered to be from inhibition of Ang $II-AT_1R$ signaling pathway such as the activation of NADPH oxidase and the generation of reactive oxygen species. In this study, we examined whether antagonist of the $AT_1R$ could account for phosphorylation of proteins in cells using antibody array. We have selected 6 proteins with Ser/Thr-phosphorylation sites and 12 proteins with Tyr-phosphorylation sites based on literature search. Upon $AT_1R$ antagonist losartan treatment to serum-starved COS-1 cells, there was ${\sim}20%$ increase of Ser phosphorylation in small GTPase RhoA. RhoA is known to be responsible for cytoskeleton rearrangement and is down-regulated upon Ser phosphorylation in vivo. Our finding provides a new insight into the mechanism and signaling pathway of the $AT_1R$ antagonist in cells.

안지오텐신II 수용체(AT1 수용체)는 혈관수축과 체내 전해질이온 조절에 중요한 역할을 한다. AT1 수용체 길항제(ARB)는 고혈압 치료에 이용되며 최근에는 당뇨병을 포함한 대사질환에 효능이 있음이 알려져 있다. 이 연구에서는 ARB 처리 후 세포 내 인산화단백질에 인산화가 일어나는지를 antibody array를 이용하여 실험하였다. 아미노산세린 및 트레오닌에 인산화되는 단백질 6개, 티로신에 인산화되는 단백질 12개에 대한 항체를 선정하여 nitrocellulose membrane에 부착시켰다. AT1 수용체를 발현한 COS-1 세포에 로사틴(losartan)을 처리하였을 때 small GTPase인 RhoA의 세린 잔기에 인산화가 20% 증가함을 관찰하였다. RhoA는 세포골격의 재배열에 중요한 역할을 하며 세린 잔기에 인산화가 되면 활성이 억제된다. 본 연구결과로부터 ARB가 AT1 수용체에 의한 혈관수축을 억제할 뿐만 아니라 새로운 세포 신호룰 생성함을 알 수 있다.

Keywords

References

  1. Hunyady, L. and K. J. Catt. 2006. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol. Endocrinol. 20, 953-970. https://doi.org/10.1210/me.2004-0536
  2. Lefkowitz, R. J. and S. K. Shenoy. 2005. Transduction of receptor signals by beta-arrestins. Science 308, 512-517. https://doi.org/10.1126/science.1109237
  3. Perez, D. M. and S. S. Karnik. 2005. Multiple signaling states of G-protein-coupled receptors. Pharmacol. Rev. 57, 147-161. https://doi.org/10.1124/pr.57.2.2
  4. Azzi, M., P. G. Charest, S. Angers, G. Rousseau, T. Kohout, M. Bouvier and G. Pineyro. 2003. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc. Natl. Acad. Sci. USA 100, 11406-11411. https://doi.org/10.1073/pnas.1936664100
  5. Wisler, J. W., S. M. DeWire, E. J. Whalen, J. D. Violin, M. T. Drake, S. Ahn, S. K. Shenoy and R. J. Lefkowitz. 2007. A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling. Proc. Natl. Acad. Sci. USA 104, 16657-16662. https://doi.org/10.1073/pnas.0707936104
  6. Ostergren, J. 2007. Renin-angiotensin-system blockade in the prevention of diabetes. Diabetes Res. Clin. Pract. 76 Suppl 1, S13-21. https://doi.org/10.1016/j.diabres.2007.01.018
  7. Leiter, L. A. and R. Z. Lewanczuk. 2005. Of the reninangiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition. Am. J. Hypertens 18, 121-128. https://doi.org/10.1016/j.amjhyper.2004.07.001
  8. Lee, C., S. Bhatt, A. Shukla, R. W. Desnoyer, S. P. Yadav, M. Kim, S. H. Jang and S. S. Karnik. 2008. Site-specific cleavage of GPCR-engaged beta-arrestin: Influence of the AT1 receptor conformation on scissile site selection. J. Biol. Chem. 10, 1074/jbc.M803062200.
  9. Luttrell, L. M., F. L. Roudabush, E. W. Choy, W. E. Miller, M. E. Field, K. L. Pierce and R. J. Lefkowitz. 2001. Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc. Natl. Acad. Sci. USA 98, 2449-2454. https://doi.org/10.1073/pnas.041604898
  10. Somlyo, A. P. and A. V. Somlyo. 1994. Signal transduction and regulation in smooth muscle. Nature 372, 231-236. https://doi.org/10.1038/372231a0
  11. Ellerbroek, S. M., K. Wennerberg and K. Burridge. 2003. Serine phosphorylation negatively regulates RhoA in vivo. J. Biol. Chem. 278, 19023-19031. https://doi.org/10.1074/jbc.M213066200
  12. Sah, V. P., T. M. Seasholtz, S. A. Sagi and J. H. Brown. 2000. The role of Rho in G protein-coupled receptor signal transduction. Annu. Rev. Pharmacol. Toxicol. 40, 459-489. https://doi.org/10.1146/annurev.pharmtox.40.1.459
  13. Barnes, W. G., E. Reiter, J. D. Violin, X. R. Ren, G. Milligan and R. J. Lefkowitz. 2005. beta-Arrestin 1 and Galphaq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation. J. Biol. Chem. 280, 8041-8050. https://doi.org/10.1074/jbc.M412924200
  14. Lee, C., S. A. Hwang, S. H. Jang, H. S. Chung, M. B. Bhat and S. S. Karnik. 2007. Manifold active-state conformations in GPCRs: agonist-activated constitutively active mutant AT1 receptor preferentially couples to Gq compared to the wild-type AT1 receptor. FEBS Lett 581, 2517-2522. https://doi.org/10.1016/j.febslet.2007.04.069
  15. Cotecchia, S., S. Exum, M. G. Caron and R. J. Lefkowitz. 1990. Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc. Natl. Acad. Sci USA 87, 2896-2900. https://doi.org/10.1073/pnas.87.8.2896
  16. Smit, M. J., H. F. Vischer, R. A. Bakker, A. Jongejan, H. Timmerman, L. Pardo and R. Leurs. 2007. Pharmacogenomic and structural analysis of constitutive G protein-coupled receptor activity. Annu. Rev. Pharmacol. Toxico.l 47, 53-87. https://doi.org/10.1146/annurev.pharmtox.47.120505.105126
  17. Alessi, D. R., M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, P. Cohen and B. A. Hemmings. 1996. Mechanism of activation of protein kinase B by insulin and IGF-1. Embo J. 15, 6541-6551.
  18. Stokoe, D. et al. 1997. Dual role of phosphatidylinositol- 3,4,5-trisphosphate in the activation of protein kinase B. Science 277, 567-570. https://doi.org/10.1126/science.277.5325.567
  19. Lang, P., F. Gesbert, M. Delespine-Carmagnat, R. Stancou, M. Pouchelet and J. Bertoglio. 1996. Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes. Embo J. 15, 510-519.
  20. Darnell, J. E., Jr., I. M. Kerr and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421. https://doi.org/10.1126/science.8197455
  21. Hibi, M., A. Lin, T. Smeal, A. Minden and M. Karin. 1993. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7, 2135-2148. https://doi.org/10.1101/gad.7.11.2135
  22. Ui, M., M. H. Sonobe, T. Ito, M. Murakami, S. Okazaki, M. Takada, T. Sato and H. Iba. 1998. Biochemical and functional analysis of highly phosphorylated forms of c-Junprotein. FEBS Lett 429, 289-294. https://doi.org/10.1016/S0014-5793(98)00618-8
  23. Keranen, L. M., E. M. Dutil and A. C. Newton. 1995. Protein kinase C is regulated in vivo by three functionally distinct phosphorylations. Curr. Biol. 5, 1394-1403. https://doi.org/10.1016/S0960-9822(95)00277-6
  24. Moore, M. J., J. R. Kanter, K. C. Jones and S. S. Taylor. 2002. Phosphorylation of the catalytic subunit of protein kinase A. Autophosphorylation versus phosphorylation by phosphoinositide- dependent kinase-1. J. Biol. Chem. 277, 47878- 47884. https://doi.org/10.1074/jbc.M204970200
  25. Zwick, E., P. O. Hackel, N. Prenzel and A. Ullrich. 1999. The EGF receptor as central transducer of heterologous signalling systems. Trends Pharmacol. Sci. 20, 408-412. https://doi.org/10.1016/S0165-6147(99)01373-5
  26. Blenis, J. 1993. Signal transduction via the MAP kinases: proceed at your own RSK. Proc. Natl. Acad. Sci. USA 90, 5889-5892. https://doi.org/10.1073/pnas.90.13.5889
  27. Raingeaud, J., S. Gupta, J. S. Rogers, M. Dickens, J. Han, R. J. Ulevitch and R. J. Davis. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270, 7420-7426. https://doi.org/10.1074/jbc.270.13.7420
  28. Calalb, M. B., T. R. Polte and S. K. Hanks. 1995. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol. Cell Biol. 15, 954-963. https://doi.org/10.1128/MCB.15.2.954
  29. Liu, K. D., S. L. Gaffen, M. A. Goldsmith and W. C. Greene. 1997. Janus kinases in interleukin-2-mediated signaling: JAK1 and JAK3 are differentially regulated by tyrosine phosphorylation. Curr. Biol. 7, 817-826. https://doi.org/10.1016/S0960-9822(06)00369-1
  30. Feng, J., B. A. Witthuhn, T. Matsuda, F. Kohlhuber, I. M. Kerr and J. N. Ihle. 1997. Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop. Mol. Cell Biol. 17, 2497-2501. https://doi.org/10.1128/MCB.17.5.2497
  31. Johnston, J. A., et al. 1994. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 370, 151-153. https://doi.org/10.1038/370151a0
  32. Derijard, B., M. Hibi, I. H. Wu, T. Barrett, B. Su, T. Deng, M. Karin and R. J. Davis. 1994. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025-1037. https://doi.org/10.1016/0092-8674(94)90380-8
  33. Lawler, S., X. H. Feng, R. H. Chen, E. M. Maruoka, C. W. Turck, I. Griswold-Prenner and R. Derynck. 1997. The type II transforming growth factor-beta receptor autophosphorylates not only on serine and threonine but also on tyrosine residues. J. Biol. Chem. 272, 14850-14859. https://doi.org/10.1074/jbc.272.23.14850